Optical coherence tomography

Article

Dr Sebasiten Wolf describes how SD-OCT has improved the visualization of intraretinal morphologic feaures both quantatively and qualatively.

The OCT technique is an interferometric imaging technique that generates cross-sectional images by mapping the reflections of low-coherence laser light from different tissue layers. Spectral or Fourier domain OCT refers to Fourier transformation of the optical spectrum of the low-coherence interferometer. With the spectral domain technique, imaging with an axial image resolution of about 5–10 µm is possible. The transversal resolution is limited by the optics of the eye, by the low numerical aperture of the optics of the illuminating beam, and the number of A-scans used to reconstruct a B-scan.

Currently, various SD-OCT instruments are commercially available. All systems provide high-quality OCT line scans as well as special scan patterns for imaging the optic nerve fibre layer around the optic disc and for producing 3-dimensional OCT images.

Most of the new SD-OCT systems image the outer retinal layers as three hyper reflective bands. The innermost of these hyper reflective bands has the lowest reflectivity. The bands may correspond to the external limiting membrane, the junction of the photoreceptor OS and IS and the RPE.

Various macular diseases have been studied and SD-OCT can aid in identifying, monitoring and quantitatively assessing various posterior segment conditions including diabetic macular oedema (DME), age-related macular degeneration (AMD), macular oedema (ME) as a result of retinal vein occlusion, disease of the vitreomacular interface such as epiretinal membranes, full-thickness macular holes, pseudoholes, schisis from myopia or optic pits, central serous chorioretinopathy, retinal detachment. At the same time it may be possible to explain why some patients respond to treatment while others do not. For example, SD-OCT is a valuable tool in determining the minimum maintenance dose of a certain drug in the treatment of DME, ME as a result of retinal vein occlusion (RVO) and wet AMD. It may demonstrate retinal changes that explain the recovery in some patients or non improvement in other patients without performing any invasive procedure such as retinal angiography.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Related Content
© 2025 MJH Life Sciences

All rights reserved.